Evogene Balance Sheet Health
Financial Health criteria checks 6/6
Evogene has a total shareholder equity of $28.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $51.1M and $22.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$31.06m |
| Equity | US$28.69m |
| Total liabilities | US$22.42m |
| Total assets | US$51.10m |
Recent financial health updates
Recent updates
Evogene unit files for EPA approval of bio-fungicide LAV.311 for fruit rots
Oct 12Evogene unit launches 2nd-gen medical cannabis products in Israel
Sep 21Lavie Bio appoints Guri Oron as CEO
Sep 14Evogene GAAP EPS of -$0.42 misses by $0.23, revenue of $0.55M beats by $0.33M
Aug 31Evogene regains compliance with Nasdaq's minimum bid price requirement
Aug 25Evogen stock rises after unit gets $10M investment from ICL under collaboration agreement
Aug 17Update On Evogene's Subsidiaries: Biomica, Lavie Bio And AgPlenus
Mar 22Evogene: Computational Biology Technology Hub; Focus On Canonic (Medical Cannabis)
Mar 03Evogene's Canonic Begins Selling High THC Cannabis In Israeli Medical Market
Sep 14Evogene: Bullish With Canonic's Entry Into Israeli Medical Cannabis Markets
Jun 16Evogene EPS beats by $0.01, beats on revenue
May 26Evogene unit - Canonic inks cultivation deal for medical cannabis varieties
Dec 23AgPlenus reaches a 'Lead' Stage in its mode-of-action herbicide program
Dec 15Evogene: Q3 Update And Upcoming Catalysts
Nov 30Financial Position Analysis
Short Term Liabilities: EVGN's short term assets ($34.5M) exceed its short term liabilities ($6.9M).
Long Term Liabilities: EVGN's short term assets ($34.5M) exceed its long term liabilities ($15.5M).
Debt to Equity History and Analysis
Debt Level: EVGN is debt free.
Reducing Debt: EVGN has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EVGN has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: EVGN has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 8.8% each year.